Lexaria (NASDAQ: LEXX) Announces Positive Interim Animal Study Results on DehydraTECH-CBD in Diabetes Control

The study is underway using diabetic, pre-conditioned Zucker rats. The results showed that DehydraTECH-liraglutide (Group H) and two DehydraTECH-CBD formulations (Groups A and B) were the top …